GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (NYSE:MDT) » Definitions » Cyclically Adjusted Price-to-FCF

MDT (Medtronic) Cyclically Adjusted Price-to-FCF : 19.54 (As of Jun. 25, 2025)


View and export this data going back to 1972. Start your Free Trial

What is Medtronic Cyclically Adjusted Price-to-FCF?

As of today (2025-06-25), Medtronic's current share price is $85.97. Medtronic's Cyclically Adjusted FCF per Share for the quarter that ended in Apr. 2025 was $4.40. Medtronic's Cyclically Adjusted Price-to-FCF for today is 19.54.

The historical rank and industry rank for Medtronic's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MDT' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 15.74   Med: 23.78   Max: 34.08
Current: 19.57

During the past years, Medtronic's highest Cyclically Adjusted Price-to-FCF was 34.08. The lowest was 15.74. And the median was 23.78.

MDT's Cyclically Adjusted Price-to-FCF is ranked better than
72.18% of 248 companies
in the Medical Devices & Instruments industry
Industry Median: 35.145 vs MDT: 19.57

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Medtronic's adjusted free cash flow per share data for the three months ended in Apr. 2025 was $1.607. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $4.40 for the trailing ten years ended in Apr. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medtronic Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Medtronic's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Cyclically Adjusted Price-to-FCF Chart

Medtronic Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.08 24.44 20.62 18.35 19.27

Medtronic Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.35 18.12 20.50 21.15 19.27

Competitive Comparison of Medtronic's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted Price-to-FCF falls into.


;
;

Medtronic Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Medtronic's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=85.97/4.40
=19.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic's Cyclically Adjusted FCF per Share for the quarter that ended in Apr. 2025 is calculated as:

For example, Medtronic's adjusted Free Cash Flow per Share data for the three months ended in Apr. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Apr. 2025 (Change)*Current CPI (Apr. 2025)
=1.607/123.8881*123.8881
=1.607

Current CPI (Apr. 2025) = 123.8881.

Medtronic Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201507 0.412 100.374 0.509
201510 0.740 100.075 0.916
201601 1.090 98.879 1.366
201604 0.687 99.875 0.852
201607 0.867 100.872 1.065
201610 0.865 99.776 1.074
201701 1.272 99.178 1.589
201704 1.045 100.773 1.285
201707 0.334 100.673 0.411
201710 0.484 100.374 0.597
201801 1.292 99.377 1.611
201804 0.546 100.374 0.674
201807 1.033 101.470 1.261
201810 0.703 101.271 0.860
201901 1.296 100.075 1.604
201904 1.296 102.068 1.573
201907 0.894 101.969 1.086
201910 1.172 101.969 1.424
202001 1.564 101.371 1.911
202004 0.825 101.969 1.002
202007 -0.041 101.570 -0.050
202010 1.169 100.474 1.441
202101 1.470 101.171 1.800
202104 1.007 103.065 1.210
202107 0.674 103.763 0.805
202110 1.105 105.557 1.297
202201 1.406 106.255 1.639
202204 1.241 110.242 1.395
202207 0.492 113.262 0.538
202210 0.450 115.315 0.483
202301 0.932 114.470 1.009
202304 1.562 118.213 1.637
202307 0.391 119.903 0.404
202310 0.150 121.111 0.153
202401 1.598 119.179 1.661
202404 1.776 121.232 1.815
202407 0.359 122.560 0.363
202410 0.430 121.956 0.437
202501 1.630 121.473 1.662
202504 1.607 123.888 1.607

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medtronic  (NYSE:MDT) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Medtronic Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Medtronic's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medtronic Business Description

Address
Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Executives
Brett A. Wall officer: EVP & Group Pres Restora Thera 710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Geoffrey Martha officer: Sr VP, Strategy & Bus Dev 710 MEDTRONIC PKWAY, MS LC300, MINNEAPOLIS MN 55432
Michael Marinaro officer: EVP & President, Surgical OU 710 MEDTRONIC PARKWAY NE, LC300, MINNEAPOLIS MN 55432
Sean Salmon officer: EVP & Group President Diabetes MEDTRONIC PLC, 710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Gregory L Smith officer: EVP Global Ops & Supply Chain 710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Hoedt Rob Ten officer: EVP & President EMEAC 710 MEDTRONIC PKWY, MSLC300, MINNEAPOLIS MN 55432
Gregory P Lewis director C/O HONEYWELL INTERNATIONAL INC., 300 SOUTH TRYON STREET, CHARLOTTE NC 28202
Lidia Fonseca director 358 SOUTH MAIN STREET, BURLINGTON NC 27215
Karen L Parkhill officer: EVP & Chief Financial Officer 1717 MAIN STREET, MC 6402, DALLAS TX 75201
Ivan K Fong officer: EVP GENERAL COUNSEL & SECR 3M CENTER, ST. PAUL MN 55144-1000
Robert John White officer: EVP & President MITG MEDTRONIC PLC, 710 MEDTRONIC PKWY MS LC300, MINNEAPOLIS MN 55432
Richard H Anderson director MEDTRONIC, INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Bradley E Lerman officer: SVP General Counsel & Corp Sec MEDTRONIC, INC., 710 MEDTRONIC PKWY MSLC300, MINNEAPOLIS MN 55432
Jennifer M Kirk officer: Chief Accounting Officer 5 GREENWAY PLAZA, SUITE 110, HOUSTON TX 77046
John R Liddicoat officer: EVP & President of Americas MEDTRONIC PLC, 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432